-
SRDX Beats on EPS, Sales Slip - Analyst Blog
Friday, January 28, 2011 - 2:00pm | 726SurModics Inc.'s (SRDX) first quarter fiscal 2011 earnings (excluding special items) of $0.05 per share was well ahead of the break even earnings suggested by the Zacks Consensus Estimate. However, earnings fell short of the year-ago earnings of $0.11. The weak year-over-year performance in the...
-
Cloud Computing Deal with Verizon and Terremark Creates Top Trader for Investors
Friday, January 28, 2011 - 1:48pm | 960Cloud Computing Deal with Verizon and Terremark Creates Top Trader for Investors POINT ROBERTS, Wash., January 28th 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on late morning trading on the NASDAQ.com. The top gainers include: (NASDAQ: CHMP...
-
Accuray Incorporated Surges; Calls Active (ARAY)
Friday, January 28, 2011 - 1:08pm | 132Shares of Accuray Incorporated (NASDAQ: ARAY) are higher on the session by 24.34%, currently trading at $8.53. The stock has been moving largely higher over the past three months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name...
-
Thoratec Results Miss Estimates - Analyst Blog
Friday, January 28, 2011 - 12:04pm | 609Thoratec Corp. (THOR) reported fourth-quarter fiscal 2010 adjusted (excluding one-time items) earnings per share of 25 cents, missing the Zacks Consensus Estimate of 27 cents while surpassing the year-ago results of 24 cents. For fiscal 2010, adjusted earnings per share of $1.12 beat the Zacks...
-
Thoratec Results Miss Estimates - Analyst Blog
Friday, January 28, 2011 - 11:30am | 609Thoratec Corp. (THOR) reported fourth-quarter fiscal 2010 adjusted (excluding one-time items) earnings per share of 25 cents, missing the Zacks Consensus Estimate of 27 cents while surpassing the year-ago results of 24 cents. For fiscal 2010, adjusted earnings per share of $1.12 beat the Zacks...
-
Piper Jaffray Maintains ResMed Overweight Rating, $38 PT (RMD)
Friday, January 28, 2011 - 10:53am | 152Piper Jaffray maintained its ResMed (NYSE: RMD) Overweight rating and $38 price target in a research report published today. In the report, Piper Jaffray states, "ResMed reported 2Q11 revenue below expectations, but delivered EPS results ahead of consensus (in-line adjusting for hedging gain)....
-
Morgan Keegan Comments On Hill-Rom Holdings In-line Earnings
Friday, January 28, 2011 - 10:20am | 158Hill-Rom Holdings (NYSE: HRC) reported fiscal 1Q results with sales $374 mn or 5% growth, and in-line with Morgan Keegan's top-line expectations. Conversely, EPS of $0.55 exceeded its $0.50 estimate and consensus estimate of $0.45 as operating margin expansion of 360 bps YoY outpaced the forecast...
-
J.P. Morgan Raises Price Target on Zimmer Holdings (ZMH)
Friday, January 28, 2011 - 10:17am | 160J.P. Morgan is out with a research report this morning, where it reiterates its Overweight rating on Zimmer Holdings (NYSE: ZMH); it has a $63.00 price target on the stock, up from $57.00. The JPM analysts cited the company's earnings release, which was “solid;” the company also provided...
-
Boston Scientific Responds to DOJ Civil Lawsuit
Friday, January 28, 2011 - 10:08am | 212Boston Scientific Corporation (NYSE: BSX) today announced that yesterday afternoon, the Civil Division of the U.S. Department of Justice (DOJ) filed a civil False Claims Act complaint against Boston Scientific, Guidant LLC and other entities. This complaint involves Guidant's conduct leading to...
-
Morgan Keegan Comments On Baxter International Following In-Line Earnings Results
Friday, January 28, 2011 - 10:02am | 147Baxter International (NYSE: BAX) reported 4Q earnings that were in-line on the top-line and $0.01 ahead of the Street consensus, but $0.01 below Morgan Keegan's forecast. Although operating margin declined more than expected, it notes unanticipated investment spending in the quarter accounted for...
-
JP Morgan Raises PT On Zimmer Holdings To $63
Friday, January 28, 2011 - 9:33am | 27JP Morgan has raised the price target on Zimmer Holdings (NYSE: ZMH) from $57 to $63 and maintains its Overweight rating.
-
Benzinga's Top Pre-Market NASDAQ Losers (INFN, PMCS, AMZN, ZOLL)
Friday, January 28, 2011 - 9:22am | 129Infinera Corporation (NASDAQ: INFN) dipped 17.59% to $7.40 in the pre-market session. INFN projected Q1 below expectations. Analysts at JP Morgan downgraded INFN from “overweight” to “neutral.” PMC-Sierra Inc (NASDAQ: PMCS) lost 12.91% to $7.76 in the pre-market session. PMCS reported lower-than-...
-
Piper Jaffray Raises PT On Accuray To $10
Friday, January 28, 2011 - 9:18am | 27Piper Jaffray has raised the price target on Accuray Incorporated (NASDAQ: ARAY) from $8 to $10 and maintains its Overweight rating.
-
Deutsche Bank Reiterates Buy On Baxter International (BAX)
Friday, January 28, 2011 - 8:35am | 124Deutsche Bank is reiterating its Buy rating and $60 price target on shares of Baxter International (NYSE: BAX). In a note to clients, Deutsche Bank writes, "4Q results were a little better than expected (except gross margins). BAX guided EPS to $4.15-$4.25 (vs. First Call $4.23), which includes $0....
-
Jefferies Maintains Hold on ResMed (RMD)
Friday, January 28, 2011 - 8:27am | 88Jefferies is out with its report on ResMed (NYSE: RMD), maintaining Hold and a $30 PT on RMD. In a note to clients, Jefferies writes, "RMD essentially reported an in-line quarter across the top-line with strong performances in masks and international flow generators being offset by a significant...